Sertraline 50 mg/day as a treatment for panic disorder

Author: Wolkow R.W.¹

Source: European Neuropsychopharmacology, Volume 7, Supplement 2, September 1997 , pp. 244-245(2)

Publisher: Elsevier

Language: English

Document Type: Abstract

DOI: 10.1016/S0924-977X(97)88808-6

Affiliations: 1: Pfizer Inc. Central Research, , United States

Links for this article

http://www.ingentaconnect.com/els/0924977x/1997/00000007/90000002/art88808
http://openurl.ingenta.com/content?genre=article&issn=0924-977X&volume=7&issue=1002&spage=244&epage=245
http://dx.doi.org/10.1016/S0924-977X(97)88808-6